Methylenedioxycyclopropylmethylamphetamine

MDCPM

Clinical data
Other names	3,4-Methylenedioxy-N-cyclopropylmethylamphetamine; MDCPM; N-Cyclopropylmethyl-MDA
Routes of administration	Oral
ATC code	None
Pharmacokinetic data
Duration of action	Unknown
Identifiers
IUPAC name N-(cyclopropylmethyl)-1-(2H-1,3-benzodioxol-5-yl)propan-2-amine
CAS Number	22698-08-4 Y
PubChem CID	71308239
ChemSpider	21106332 N
UNII	X8VGM9CN9J
CompTox Dashboard (EPA)	DTXSID60745440
Chemical and physical data
Formula	C14H19NO2
Molar mass	233.311 g·mol−1
3D model (JSmol)	Interactive image
SMILES C3OC1C(C=CC(=C1)CC(C)NCC2CC2)O3
InChI InChI=1S/C14H19NO2/c1-10(15-8-11-2-3-11)6-12-4-5-13-14(7-12)17-9-16-13/h4-5,7,10-11,15H,2-3,6,8-9H2,1H3 N Key:AEIQNPMGFQNZNV-UHFFFAOYSA-N N
NY (what is this?)  (verify)

MDCPM, also known as 3,4-methylenedioxy-N-cyclopropylmethylamphetamine or as N-cyclopropylmethyl-MDA, is a drug. It is the N-cyclopropylmethyl derivative of MDMA.

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDCPM's minimum dose as 10 mg orally and its duration as unknown. MDCPM produces few to no effects.

History

MDCPM was described in a patent by Horrom in 1972. Subsequently, it was described in greater detail by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved).

Chemistry

Society and culture

See also

• Substituted methylenedioxyphenethylamine